FindTrial
Sign In

Expanded Access for Mezigdomide

Status
AVAILABLE
Phases
Unknown
Study type
Expanded Access
Source
ClinicalTrials.gov
Registry ID
NCT06994117
Enrollment
Unknown
Registered
2025-05-29
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This is an expanded access designed to provide access to Mezigdomide for eligible participants.

Interventions

DRUGMezigdomide

Mezigdomide

Sponsors

Bristol-Myers Squibb
Lead SponsorINDUSTRY

Eligibility

Inclusion criteria

\-

Exclusion criteria

\-

Contacts

Primary ContactBMS Clinical Trials Contact Center www.BMSClinicalTrials.com
Clinical.Trials@bms.com855-907-3286
Backup ContactFirst line of the email MUST contain the NCT# and Site #.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026